- Home
- SEER vs DMA Comparison
SEER vs DMA Comparison
Compare SEER & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SEER | DMA |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.2M | 80.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SEER | DMA |
|---|---|---|
| Price | $1.85 | $8.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 188.3K | 34.6K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,376,999.00 | N/A |
| Revenue This Year | $22.37 | N/A |
| Revenue Next Year | $30.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.11 | N/A |
| 52 Week Low | $1.62 | $4.78 |
| 52 Week High | $2.50 | $8.00 |
Technical Indicators
Market Signals| Indicator | SEER | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 54.40 |
| Support Level | $1.80 | $8.97 |
| Resistance Level | $1.88 | $9.15 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 47.37 | 26.09 |
Price Performance
Historical ComparisonAbout SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.